Skip to content

Tailored Web-Based Intervention for Cancer Patients and Family Caregivers

Tailored Web-Based Intervention for Cancer Patients and Family Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01415089
Acronym
FOCUS-WEB
Enrollment
63
Registered
2011-08-11
Start date
2009-05-31
Completion date
2011-06-30
Last updated
2015-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer

Keywords

Cancer, Quality of life, Family caregiver, Stress and coping, Web-based intervention, Communication

Brief summary

The purpose of this pilot study is to develop a personalized, interactive, and web-based module for cancer patients and a family caregiver. The three-session module will be designed to help patients and family caregivers improve their communication and support.

Detailed description

This R21 will be used to develop an individually tailored, interactive, web-based intervention for cancer patients (lung, colorectal, breast, prostate) and their family caregivers. This intervention is based on an efficacious, family-based program of care (the FOCUS Program) that has been tested previously in three large randomized clinical trials with positive outcomes for patients and their caregivers. In this R21 we will translate this primarily face-to-face, family-based program to an internet-based version. The objectives are: Objective 1. To develop an individually-tailored, interactive, web-based and email-based, Family Involvement Module. We will conduct formative testing while developing the module using qualitative data obtained from four focus groups. We will conduct usability testing of the near final module with data obtained from qualitative interviews with patients and caregivers as they complete web-based task assignments using a think aloud protocol while they navigate the module. Objective 2. To conduct a Phase II study with cancer patients and their family caregiver (N = 40 dyads) using baseline (Time 1) and two-month follow-up assessments (Time 2). Between Times 1 and 2, all participants jointly will complete the web-based Family Involvement Module. We will determine the feasibility of delivering the web-based module and will obtain a process evaluation completed by study participants. Data will be obtained from three large cancer centers using established instruments, and analyzed with descriptive statistics and paired t-tests. Findings from this R21 will provide data that are essential to test this innovative, tailored, interactive web-based intervention with a larger sample in a R01.

Interventions

BEHAVIORALFOCUS-Web

A 3-session individually tailored, interactive, web-based program providing support and education for cancer patients and one of their family caregivers.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Wayne State University
CollaboratorOTHER
Barbara Ann Karmanos Cancer Institute
CollaboratorOTHER
Trinity Health Michigan
CollaboratorOTHER
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cancer patients with confirmed diagnosis of breast, colorectal, lung or prostate cancer * early stage (I or II, diagnosed within past 2 to 12 months) OR advanced stage (III or IV, diagnosed or progressed within past 2 to 12 months) * age 18 or older * physically/mentally able to participate * speak/read/write English * have access to internet at home * have a family caregiver willing to participate * family caregivers must be age 18 or older, physically/mentally able to participate, able to speak/read/write English, identified by the patient as his or her primarily family caregiver, and have access to and willing to use the internet. Family caregiver is defined as the family member or significant other identified by the patient as his or her primary source of emotional or physical support during the current cancer experience and confirmed by the designated individual.

Exclusion criteria

* Family caregivers will be excluded from the study if they themselves have been diagnosed with cancer in the previous year or are receiving active treatment for cancer. This criteria was established so all dyads are managing effects of cancer in patients, not the family caregivers.

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of quality of life (FACT-G Scale) will be conducted.

Secondary

MeasureTime frameDescription
Dyadic supportBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of dyadic support (Support Scale) will be conducted.
Self-efficacyBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of self-efficacy (CASE Scale) will be conducted.
CommunicationBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of communication (MIS Scale) will be conducted.
Emotional distressBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of emotional distress (POMS Scale) will be conducted.
Satisfaction with intervention2 months after baseline survey (Time 2)An assessment of the patients' and family caregivers' level of satisfaction with the intervention (Process Evaluation) will be conducted.
Perceived benefits of illnessBaseline (Time 1) and 2 months (Time 2)A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of perceived benefits of illness (BOI Scale) will be conducted.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026